Skip to main content Skip to navigation

News file

Unproven procedure halted after serious adverse events

02 March 2010

The latest issue of the journal Annals of Neurology reports on two serious incidents which led to the suspension of further procedures to treat CCSVI at Stanford Medical Center.

New assisted suicide guidelines published

26 February 2010

The Director of Public Prosecutions (DPP) has issued new guidelines on whether someone will be prosecuted for helping someone to die.

Super Hero 5K fun runs in London & Manchester

25 February 2010

Free super hero suit with every entry!

MS Trust supports RCN's call for more investment in specialist nurses

24 February 2010

The MS Trust supports the call by the Royal College of Nursing (RCN) for greater investment in specialist nurses to support people with long-term conditions such as multiple sclerosis (MS).

Teen soap tackles MS

23 February 2010

Teen soap Hollyoaks, which was aired recently on Channel 4 has introduced a storyline depicting one of its characters living with MS.

Fingolimod granted priority review in the States

22 February 2010

Fingolimod (brand name Gilenia) is a new oral treatment for relapsing remitting MS. Applications for licensing were submtted to the regulators in the US and Europe in December 2009. The Food and Drug Administration (FDA) in the US has granted priority review to fingolimod.

MS Trust comments on Radio 5 Risk-sharing Scheme programme

22 February 2010

The Donal MacIntyre show on Radio 5 covered the Department of Health Risk-sharing Scheme last night.

Vitamin D - the latest information

18 February 2010

With much data being published recently about the influence of sunlight and vitamin D on the incidence of MS the MS Trust has produced a new factsheet summarising the latest information.

MS Trust comments on new data on CCSVI

12 February 2010

Preliminary results from a study of CCSVI report an association with people with MS.

Making information about medicines available online

09 February 2010

The MHRA (Medicines and Healthcare products Regulatory Agency), the UK medicines' regulator, is seeking views on making information on medicines available to the public.

MS Trust welcomes further research into CCSVI

09 February 2010

A number of trials are planned looking at the theory that blocked veins may be a contributory factor in multiple sclerosis.

MP calls for abolition of the MS drugs risk-sharing scheme

08 February 2010

The Risk-sharing Scheme, the mechanism that makes disease modifying drugs for MS available on the NHS, was debated in Parliament on 2 February.

Oral drugs for MS

02 February 2010

With the new oral drugs continuing to be a focus of interest, the MS Trust has put together information on the research into cladribine and fingolimod.

Experience Britain's greatest Roman monument

01 February 2010

Visit 2,000 years of history in just one weekend

Exciting new exercise resource launched for people with MS

01 February 2010

Following the success of the book Exercises for people with MS, the MS Trust has launched a new set of web pages full of exercises for people with MS.

More oral MS drug research results published

26 January 2010

Research published in the New England Journal of Medicine (NEJM) suggests that the oral drug cladribine reduces relapse rates and disease progression in people with relapsing remitting MS.

Update - fampridine approved by US drugs regulator

25 January 2010

The US Food and Drug Administration (FDA) has approved fampridine - brand name Ampyra - as a treatment to improve walking ability in people with multiple sclerosis.

Tysabri labelling changes recommended

22 January 2010

The European Medicines Agency has recommended new measures for dealing with the risks associated with the drug natalizumab (Tysabri).

Oral MS drug research results published

21 January 2010

Research published online today in the New England Journal of Medicine (NEJM) suggests the new oral drug fingolimod may be more effective than current disease modifying drugs for MS.

Has MS affected your work?

20 January 2010

The Multiple Sclerosis International Federation (MSIF) is carrying out a global survey to find out more about how having MS impacts on employment.

Fampridine submitted to licensing body

13 January 2010

Fampridine, a new oral drug to improve walking ability in some people with multiple sclerosis, has been submitted for a licence to the EMEA, the European regulator.

MS Trust remains cautious about CCSVI

12 January 2010

With CCSVI again in the news, the MS Trust suggests caution in considering surgery based on what is still a theory being investigated by researchers.

MS Circuit Challenge at Goodwood Motor Circuit

11 January 2010

A fun packed day is on offer with a cycle race around the motor circuit in the morning, followed by a family event in the afternoon where you can complete the circuit "by any means"!

American researchers to explore stem cell repair procedure

08 January 2010

Researchers in the USA are recruiting for a trial that will look at the safety and tolerability of a procedure that attempts to treat MS damage in the central nervous system with an individual's own stem cells.

Run 10K for MS in 2010

07 January 2010

Sign up now for the Great Manchester Run or the British 10K London Run. Teams of six benefit from reduced sponsorship rates!

Medications organiser iPhone app launched

05 January 2010

A iPhone application to help people manage their injections has been developed by a man with multiple sclerosis.

MS more prevalent in people born in spring

04 January 2010

Newly published research from Scotland suggests that babies born in spring face an increased risk of developing multiple sclerosis later in life.

The MS Trust welcomes review of research into cannabis

23 December 2009

A systematic review of randomized controlled trials has reported that cannabis can reduce spasticity in people with multiple sclerosis (MS).

Revised ABN guidelines published

23 December 2009

At long last the new Association of British Neurologists (ABN) revised (2009) guidelines for prescribing disease modifying drugs in multiple sclerosis have been published.

MS Trust Christmas opening

22 December 2009

The MS Trust Information Service will be open on the following days.

Keep in touch with the MS Trust

22 December 2009

Trying to keep up to date with MS can sometimes seem overwhelming. To help you get straight to the information you want, there are a number of ways you can have news about MS and the work of the MS Trust sent to you directly.

MS Trust suggests caution about CCSVI

22 December 2009

CCSVI (chronic cerebro-spinal venous insufficiency), the theory that an abnormal narrowing in blood vessels that take blood from the brain might be a cause of MS symptoms or perhaps MS itself, remains a widely discussed topic in the media.